Search
Download pdfHigh School Drives Safety Report

In recent years, there has been a rapid increase in high school blood drives.  Blood bank organizations like the American Red Cross have increasingly looked to 16 and 17-year olds as a critical resource for meeting our nation’s blood supply needs.  Donating blood is safe.  But a major study published in the Journal of the American Medical Association (JAMA), in 2008, found that teenage donors are significantly more likely to experience donation-related medical complications. Adverse reactions like fainting and bruising after donating blood occurred in 10.7% of 16 and 17-year olds, as compared with 2.7% of donors 20-years and older.  While not evaluated in the study, major adverse reactions, although rare, may also occur, including prolonged loss of consciousness, large hematomas, and arterial puncture. The study concludes:

A higher incidence of donation-related complications and injury occurs among 16- and 17-year-old blood donors compared with older donors. The increasing dependence on recruiting and retaining young blood donors requires a committed approach to donor safety, especially at high school blood drives.

Soon after the JAMA study was released, the New York Times published an article entitled, High School Blood Drives Pose Extra Risks. The report suggested that parents may want to talk to school officials about safety precautions at blood drives. 

The following recommendations are intended to assist parents, PTA’s, school administrators, and high school blood drive coordinators, with ensuring that best safety practices are applied at your high school blood drive. It is your right, and responsibility to work with your mobile blood drive operator, to help keep your blood drive safe.

Recommendations for Parents, School Administrators, and High School Drive Coordinators
The Workers Committee for Blood Safety includes licensed nurses, phlebotomists, and blood drive staff with extensive experience with teen donors at high school blood drives. We fully support high school blood drives, and encourage teens to consider becoming blood donors.

Based on the medical literature and the experience of our members, we recommend that you reach an understanding with your mobile blood operator to address the following safety concerns as you plan your next blood drive:

  1. assignment of licensed nurses to your blood drive;
  2. adequate blood drive staffing;
  3. enforcement and parental notification of height and weight eligibility requirements;
  4. investigation of all major adverse reactions and injuries that may occur on your drive;
  5. protection of privacy and proper blood drive setup;
  6. be aware of the Red Cross safety record in your area



(1) Will a Registered Nurse (RN) and Licensed Nurses Be Assigned to your Blood Drive?

According to the American Association of Blood Banks (AABB), assigning extra or experienced staff to high school blood drives may “mitigate the rate and impact of donor reactions.”  

The Committee believes that one RN, and preferably a second licensed nurse should be present at every high school blood drive.  RNs and LPNs have extensive medical training and greater experience to make medical assessments, and respond to donor reactions or injuries.  A licensed nurse at your drive may be particularly important if the staff assigned to your drive lack adequate training, medical education, and experience.

During regulatory inspections in two Red Cross Regions – the Greater Alleghenies Region, and the Ozark- Arkansas Region – the FDA observed that Red Cross failed to assure that personnel have necessary training, and a thorough understanding of operations which they perform.  In the Greater Alleghenies Region, these problems involved the failure to provide employees with proper and/or have proper written procedures for use of certain equipment. Take a look  In the Ozark-Arkansas Region, the FDA observed that collections staff did not understand blood safety procedures for proper deferral of donors. Take a look

Current Red Cross practices vary, in terms of assigning nurses to high school blood drives.  In some locations, one or two nurses, are regularly assigned to high school drives.  In other locations, Red Cross operates high school drives without assigning any licensed nurses.  Blood drive workers also report that some regions do not require that all blood drive staff maintain current CPR certification.  We believe that Red Cross should adopt, publicize and enforce a consistent policy that reflects best safety practices. 

Recommendation:  Contact your blood drive operator and make sure that a minimum of one registered nurse (RN); and preferably, a second licensed nurse be assigned to your high school blood drive. 


(2) Will Your High School Drive be Adequately Staffed?
Over the past year, the FDA has issued inspection reports in two Red Cross regions that observed understaffing at blood drives. In the Heart of America Region, and the Connecticut Region, FDA observed,  “The personnel responsible for the collection of blood or blood components are not adequate in number to assure competent performance of their assigned functions, and to ensure that the final product has the safety purity, potency, identity, and effectiveness it purports or is represented to possess.” 

In the Heart of America Region, FDA reported to Red Cross, “According to your staffing matrix, specific numbers of employees are required to be present at mobile blood drives.  ARC Heart of America Region operation records reviewed during your inspection reveal blood drives are not staffed adequately and according to the firm’s matrix.” Take a look

The FDA observed four examples of understaffed drives - two at high schools and two at churches.  FDA indicated that each of these drives were understaffed based on the collection goal, the projected number of whole blood procedures, and the total number of hours scheduled for the drives. In addition, at five blood drives, including one at a high school, when the blood drive coordinators complained about inadequate staffing in blood drive sponsor surveys, Red Cross did not follow procedures for evaluating and/or investigating these staffing complaints.

In an inspection report issued to the Red Cross Connecticut Region, the FDA again stated that the blood drive staff, were not adequate in number to assure competent performance of their assigned functions.  Based on a review of operational records, FDA identified examples of six mobile drives that were not staffed adequately.Take a look 

FDA did not specify whether these mobile drives took place at high schools or at other locations. 

Finally, blood drive RNs and phlebotomists report that at high school blood drives, when one teen donor has an adverse reaction and passes out, it is not uncommon for other teens to follow with their own adverse reactions.  Blood drive workers describe this phenomenon as, “dominos,” or “contagious fainting.”   Under these circumstances, workers report that adequate staffing may help keep the blood drive from becoming too chaotic.

Recommendation:  Regardless of size, every high school drive should have two additional staff assigned above the normal Red Cross staffing matrix.  If more than 150 students intend to give blood at the drive, three additional staff should be assigned.


(3) Will Height and Weight Safety Requirements Be Enforced?
In addition to age, the medical literature has shown that donor gender, height and weight are key factors for assessing risk of adverse reactions.  Low weight teens with less blood volume, are at greater risk of experiencing a loss of consciousness, which may result in injury.

To address this problem, many blood collection operations, including Red Cross, have raised height and weight requirements for all high school students.  While these new policies are an important change, we believe that implementation of the requirements is compromised.  Students are asked their height and weight before they donate blood, but Red Cross maintains a policy to not measure and weigh students to determine whether they actually meet eligibility requirements.

Recommendation:   Every high school blood drive should be equipped with scales so that each student is weighed and measured to determine whether they meet requirements for donating blood.

In many states, 16-year olds are allowed to donate with written parental consent.  The parental consent forms provide a great deal of useful information, but may not inform parents of the specific height and weight requirements.  Without having been informed of these requirements, a parent may unknowingly provide written permission for their child to give blood even though their child should be ineligible to donate blood. Parents should also be aware if their child is on the borderline of meeting height and weight requirements.  In these situations, a parent may want to consider waiting an additional year before their child becomes a blood donor.   

Recommendation:  Review the parental consent forms and determine if they provide all needed information.  In particular, consider having the blood drive operator provide parents with a consent form that includes the height and weight safety requirements.


(4) When a Blood Donor Has a Reaction or Injury, Will Red Cross Do Proper Follow-Up? 
Over the past year, FDA has issued inspection reports observing that nine Red Cross regions across the country failed to properly report and/or investigate donor reactions and injuries.  The nine Red Cross regions listed in these inspection reports include: Arizona, Great Lakes, Greater Alleghenies, Heart of America, Indiana-Ohio, Missouri-Illinois, Northern Ohio, Southeast Michigan, and Tennessee.  

Thorough and proper investigation of adverse reactions and injuries may help to ensure that a donor receives follow-up treatment.  Investigations and reviews are also designed to determine whether the donor should be allowed to donate in the future based on medical assessment and donor safety concerns. 

Some example of FDA inspection observations that indicate that Red Cross did not report or thoroughly investigate all adverse reactions are as follows:

  • In the Red Cross Heart of America Region, the firm received a complaint via email from a mother of a 16-year old donor who donated at a high school blood drive.  According to the email, the mother states in part, “. . . my daughter had one finger pricked and they told her she was anemic so they said, that’s ok we will prick the other finger.  After she gave blood, they sat her in a chair and she passed out and hit her head very hard on the floor . . . My daughter has a large bump on her head and her neck is quite swollen . . .”   According to the FDA investigation and observation report:  1) when the donor failed the initial test, there was no documented justification for repeating the test;  2)  the donor was determined eligible to donate even though the team supervisor reported having concerns regarding the donor’s ability to meet the weight and height eligibility requirements for donors less than nineteen years of age; 3)  there was no Donor Reaction Injury Report, or documentation of the adverse reaction on the Blood Donation Record (BDR) and;  4) during the FDA inspection, the team supervisor stated that a volunteer at the drive had told the supervisor that the donor had a loss of consciousness and had fallen on the floor, however, the team supervisor did not know the length of time in which the loss of consciousness occurred. Take a peek

  • In the Southeast Michigan Region, the following incidents were not reported to the Red Cross Risk Management Officer as required:  1) A donor fell at the collection site, causing a cut to lip with some bleeding, went to the emergency room and had stitches placed in lower lip; 2) At collection site, donor experienced tetany of fingers and a swollen tongue with bluish color.  The donor had a change of speech and was transported to the hospital via emergency medical service; and 3) Donor became dizzy and incontinent secondary to donation and was taken to the emergency room. Take a Look

  • In the Indiana-Ohio Region, the Red Cross medical director review was not completed on three Donor Reaction and Injury Reports and it was completed over three weeks after the reaction on nine others.  One of the Donor Reaction and Injury Reports missing the medical director review involved a donor under age 19 who experience a twisted ankle during a “less than one minute” loss of consciousness with prolonged recovery. Take a look

  • In the Tennessee Valley Region, 49 of 110 Donor Reaction and Injury Report forms were not completed and/or documented as required. Take a look

Recommendation:  If a donor has a serious adverse reaction, ask the blood drive supervisor whether a Donor Reaction and Injury Report has been initiated and whether documentation of the reaction has been recorded in the donor’s Blood Donation Record.


(5) Will Red Cross ensure that donor privacy is protected and your blood drive is set up properly?

 In four Red Cross regions, the FDA observed failures to provide privacy for examinations of individuals to determine suitability as blood donors.  Privacy is important because donors must be truthful when questioned about their sexual and medical history.  The lack of privacy during donor screening was observed in regions including Southern California Look, Connecticut Look, Badger-Hawkeye Look, and Heart of America Look

Another high school set-up consideration is including a floor mat station or adding mats to your canteen area.  After the donor’s blood is drawn, we believe it is best that students be escorted to an area where they can sit down on floor mats for 10 to 15 minutes.  If an adverse reaction occurs, injuries can be avoided that might otherwise happen if the donor is sitting up in a chair or standing in a canteen area.  Directing students to sit on floor mats after donation, is a common sense approach to reducing the chance of injuries. Currently, Red Cross uses floor mats on some high school blood drives, but not others.

Recommendation:  During the setup of your blood drive, review the layout and determine if screening areas protect the privacy of students when they are providing their donor history information.  If privacy is not protected, talk to the blood drive supervisor about making changes in the setup.

Recommendation:  If possible, set up a mat station in, or near the canteen area, where donors can sit down and relax for 10 to 15 minutes.  


(6) What is Your Red Cross Region’s Record on Blood Safety and Blood Product Recalls?

For 18 years, the American Red Cross has been under a Federal Consent Decree that orders improvements in its blood safety practices.  Despite this court order, compliance problems have persisted. Since 2003, the FDA has fined Red Cross $37 million for safety compliance violations.  The most recent fines occurred in June 2010, when FDA fined Red Cross $16 million. A portion of these fines was for the release of unsuitable blood products that had to be recalled.  The FDA described these releases as preventable by Red Cross. Some of the regions with significant compliance problems are listed below.

Red Cross Region

FDA Recall Fines Issued in June 2010

Penn-New Jersey Region

$2.8 million

Southwest Region

$1.2 million

Carolinas Region

$818,000

Tennessee Valley Region

$789,000

Alabama Region

$780,000

Heart of America

$717,000

Badger-Hawkeye Region

$636,000

New England Region

$475,000

Greater Chesapeake and Potomac

$461,000

  Source: FDA Class II Recalls and Associated Fines Issued June 17, 2010

According to FDA records, many of these recalls were the result of errors made at blood drives, including: inadequate arm preparation that may have compromised sterility of blood products; errors made determining donor eligibility to give blood; and quality control associated with equipment used on blood drives.  Other fines are linked to blood component preparations, and failures to perform proper testing on blood.  Examples of these violations are below.

Recommendation:  Be aware of any safety violations and inspection reports that have been issued to Red Cross in your area.  If you want the facts, ask your Red Cross representative to provide you with: 

  1. copies of FDA Form 483 Inspection and Observation Reports issued to your blood region over the past three years; and
  2. copies of the most recent FDA Adverse Determination Letters (ADLs) that list compliance violations and fines in your blood region.

The following excerpt is from Page 2, of this 5 page Inspection Report:

OBSERVATION 2: The personnel responsible for the collection of blood or blood components are not adequate in training and experience, including professional training as necessary to assure competent performance of their assigned functions, and to ensure that the final product has the safety, purity, potency, identity, and effectiveness it purports or is represented to possess. Specifically, on December 4, 2008, Region employee [REDACTED TEXT] further identified as the Assistant Director of Collections, sent a memorandum to "All Collection Staff" that directed the use of hand warmers on the hands of donors prior to the performance of a finger stick. . . The Region has failed to create and implement training specific to the utilization of hand warmers.

Download the PDF file to read the complete FDA Inspection Observation Report

The following excerpt is from Page 1, of this 2 page Inspection Report:

OBSERVATION 1: Failure to assure that personnel have the necessary training in and a thorough understanding of the operations which they perform. Specifically, while conducting employee evaluations, I observed Collection employee [REDACTED TEXT] conducting the uniform Donor History Questionnaire. When asked the question, "In the last 12 months have you had an accidental needle stick," the donor, a health care worker, stated yes, she had been stuck by a used needle within the last 12 mos. She couldn't remember the exact date, but stated it was in October, 2008. Staff person [REDACTED TEXT] entered Oct. 1, 2009 into the electronic Blood Donor Registration (eBDR) system, and stated that they were told to use the first day of the month when they didn't know the exact date. I explained that it should be Oct. 31st to include all of October into the deferral period as using the first day of the month would shorten the deferral to possibly 11 months.

Download the PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 10, of this 11 page Inspection Report:

The personnel responsible for the collection of blood or blood components are not adequate in number to assure competent performance of their assigned functions, and to ensure that the final product has the safety purity, potency, identity, and effectiveness it purports or is represented to possess. Specifically, According to your staffing matrix, specific numbers of employees are required to be present at mobile blood drives. ARC Heart of America Region operation records reviewed during this inspection reveal blood drives are not staffed adequately and according to the firm's matrix. For example,

1. A high school drive that took place on 10/28/2009 stated that the goal of the drive was [REDACTED TEXT] projected whole blood procedures and the total number of scheduled drive hours was [REDACTED TEXT]. According to your firm's staffing matrix, this drive should have been staffed with [REDACTED TEXT] employees. According to the operation record, [REDACTED TEXT] employees were present at the drive. Additionally, the high school coordinator of the blood drive documented, through the blood drive sponsor survey, dissatisfaction with the staffing levels at the drive.

2. A high school drive that took place on 11/6/2009 stated that the goal of the drive was [REDACTED TEXT] projected whole blood procedures and the total number of hours scheduled for the drive was [REDACTED TEXT] hours. According to your firms staffing matrix, this drive should have been staffed with [REDACTED TEXT] employees. According to the operation record, [REDACTED TEXT] employees were present at the drive. Additionally, the high school coordinator of the blood drive documented, through the blood drive sponsor survey, dissatisfaction with the staffing levels to meet the needs of the drive.

Download the PDF file to read the complete FDA Inspection Observation Report

The following excerpt is from Page 3, of this 5 page Inspection Report:

The personnel responsible for the collection of blood or blood components are not adequate in number to assure competent performance of their assigned functions, and to ensure that the final product has the safety purity, potency, identity, and effectiveness it purports or is represented to possess. Specifically, mobile blood drives are not adequately staffed per staffing matrix/staff version. According to your staffing matrix, line staff, charge staffs, and mobile unit assistance (MUA) are required to be present at mobile blood drives. In addition to the above mentioned staffs, team supervisor is required if the blood drive has over [REDACTED TEXT] donors. ARC Connecticut and New England Region Blood Services Operations Records Addendum reviewed during this inspection reveal blood drives are not staffed adequately. For Example:

a.) [REDACTED TEXT] drive that took place on 4/16/2009 stated that the goal of the drive was [REDACTED TEXT] productive donors and the total hours of operation for the drive were 5 hours and 15 minutes. According to your firm's staffing matrix, this drive should have been staffed with five phlebotomists. Our audit of operation report for this drive showed there were only three phlebotomists present.

Download the PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 5, of this 11 page Inspection Report:

OBSERVATION 3: A thorough investigation of each reported adverse reaction was not made. Specifically,

A. There is not Donation Reaction and Injury Record, or documentation of an adverse reaction on the Blood Donation Record (BDR) when a donor experience an adverse reaction at the firm or when the firm received a post donation report indicating that the same donor experienced an adverse reaction at the collection site . . .

On 5/20/2010 the firm received a complaint in an email that was forwarded by a blood drive coordinator at a high school. The email was from the mother of a sixteen year old who donated at a high school blood drive on 5/19/2010. According to the email, the complaint states in part, … "my daughter had one finger priced and they told her she was anemic so they said that's ok will prick the other finger. After she gave blood they sat her in a chair and she passed out and hit her head very hard on the floor….My daughter has a large bump on her head and her neck is quite swollen…".

Download the PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 1 and 2 of this 8 page Inspection Report:

1. Work Instruction: Determining the Need for Risk Management Notification [REDACTED TEXT] state at a minimum the following incidents must be reported to the risk management officer (RMO): donor requires transport to a medical facility…donor sought medical treatment. Eight donor reaction and injury cases reported/occurring on 11/10/08, 11/12/08, 11/16/08, 02/22/09, 03/10/09, 03/17/09, 04/06/09, and 12/23/09 were not reported [to] the risk management officer.

[REDACTED TEXT]- On 11/10/08 donor [REDACTED TEXT] fell at the collection site, causing a cut to [REDACTED TEXT] lip with some bleeding. [REDACTED TEXT]T] went to the emergency room and had stitches placed in [REDACTED TEXT]] lower lip. [REDACTED TEXT]]- On 11/12/08 donor [REDACTED TEXT]] while at the collection site, experienced experienced tetany of fingers and a swollen tongue with bluish color. The donor had a change of speech and was transported to the hospital via emergency medical service (EMS).

Download the PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 2 of this 2 page Inspection Report:

Observation 2
Failure to perform thorough investigation, including conclusions and follow up of each reported donor adverse reaction Specifically, we reviewed 24 of 51 "Major" Donor Adverse Event files from September 1, 2009 and found the following delinquent or missing reviews:

1. The Medical Director Review was not completed on 3 Donor Reaction and Injury Reports and it was completed over three weeks after the reaction on 9 others. One of the Donor Reaction and Injury Reports missing the Medical Director review (Case # [REDACTED TEXT] involved a donor under age 19 who experienced a twisted ankle during a "less than one minute" loss of consciousness with prolonged recovery.

2. The "Final Quality Review" of the Donor Reaction Injury Report was not performed on 11 of 24 reactions and was performed more than 2 months after the Medical Director Review on 4 occasions.

Download the PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 1 of this 3 page Inspection Report:

1) The review of 110 Donor Reaction and Injury Record forms (56 completed by the [REDACTED TEXT] and 54 completed by the [REDACTED TEXT] during the current inspection that were completed after the last inspection in 2009 revealed that 49 out of the 110 Donor Reaction and Injury Record forms were not completed and /or documented as required by the instructions in Doc No 15.4.frm015 Version 1.2 in effect during the time frame reviewed.

Download PDF file to read the complete FDA Inspection Observation Report.]

The following excerpt is from Page 16 of this 21 page Inspection Report:

13. On 8/17/10, [REDACTED TEXT] observed donor self-administered questions being conducted without visual privacy at a blood mobile using two self-contained buses. Three out of five screening booths lacked visual privacy. For example [REDACTED TEXT] and [REDACTED TEXT].

Download PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 2 of this 5 page Inspection Report:

Privacy G. [REDACTED TEXT] date 3/2/2009, Operationa Analysis "Site is very tight – confidentiality is hard to maintain – registration and reading in hallway."

Download PDF file to read the complete FDA Inspection Observation Report.

The following excerpt is from Page 1 of this 1 page Inspection Report:

OBSERVATION 1
Failure to provide adequate space for private examinations of individuals to determine their suitability as blood donors.

Specifically, On 5/26/10, 7 donors observed after completing the self-administered questionnaire portion to be waiting outside other donor history booths. The donors who were observed waiting for their questionnaire review were able to listen and see other donors completing their questionnaire review conducted by firm personnel. The firm failed to provide appropriate privacy for donors being reviewed in these booths.

Download PDF file to read the complete FDA Inspection Observation Report.
The following excerpt is from Page 1 of this 1 page Inspection Report:

OBSERVATION 1
Failure to provide adequate space for private examinations of individuals to determine their suitability as blood donors.

Specifically, privacy was not maintained when employee [REDACTED TEXT] screened Donor # [REDACTED TEXT]. While standing outside the screening booths and beside the donor collection area, I could hear [REDACTED TEXT] read the screening questions to Donor [REDACTED TEXT] and I could hear Donor "[REDACTED TEXT] respond to the screening questions.
Download PDF file to read the complete FDA Inspection Observation Report.
Contact Us Terms of Use Privacy Policy Join the Committee for updates and future action! 2010 FDA Inspection Reports of ARC Facilities IWJ Relisious Leaders Issue Guide for Blood Drives